GlobeNewswire

Changes to Skilled Worker Visas will impact access to global executive talent pool, says AESC

Dela

Call to reconsider visa changes in light of negative 'unintended consequences'

 

SYDNEY, Australia, May 31, 2017 (GLOBE NEWSWIRE) -- There was collective concern expressed this week amongst members of the Association of Executive Search and Leadership Consultants (AESC) over the impact of recent changes to immigration regulations. It was agreed the changes may detrimentally affect Australia's ability to attract high calibre global talent. The AESC members are drawn from the top executive search and leadership advisory firms across Australia.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/e6feb0f1-41e3-4a21-97e6-2300cdce7b5c

"We are collectively concerned that the mooted changes to Australia's Skilled Worker Visa arrangements will impact access to the global executive talent pool," said Graham Willis, AESC Chair for Australia. "On a daily basis our members are dealing with the deep executive talent pools that exist within Australia. However, these talent pools do not always offer the depth of executive experience needed to meet the future needs of a business. With executive recruitment now a global story and given rapid disruptive changes in the market, Australian companies must ensure they are globally competitive."

Mr Willis said there were thus many times that executive search and leadership advisory firms needed to step outside Australia, tapping into overseas talent or attracting the rich experience of Australians who have built careers overseas.

"The decision by a Senior Executive to relocate-whether for offshoring or onshoring-is not one taken lightly; nor is the decision by Australian companies to employ overseas talent," he said. "It is significant that the collective view of Australian AESC members this week was that the proposed 457 and 186 visa changes are likely to be counterproductive in attracting the very best executive talent to Australia."

The comments follow the 18 April 2017 announcement by the Australian Prime Minister, the Hon Malcolm Turnbull MP, and his Minister for Immigration and Border Protection, the Hon Peter Dutton MP, and reference their proposal that the Temporary Work (Skilled) visa (subclass 457 visa) be abolished and replaced with the new Temporary Skill Shortage (TSS) visa. Changes to the subclass 186 visa were also announced-including the extension of age limits. These would set a new maximum age limit of 45 years old for executive-level professionals to obtain 186 visas, significantly restricting Australia's access to +45 year old top senior executive talent.

"The executive search and leadership consulting profession recognises the benefits of promoting local talent pools, however, AESC's central concern is that the proposed visa changes will serve to restrict onshoring of key leaders and access to specific and specialised skills in the global market," said Graham Willis.

Mr Willis noted that diversity of talent was essential to Australia's economic success, especially leaders who bring experience working in global markets or with specific skills. The skills and background required for successful senior level appointments cannot always be found locally, and for businesses to gain a competitive advantage in their increasingly global industries, mobilisation of executive talent across borders is critical.

AESC members also expressed concern about the proposal to establish a new two-year renewable visa-only able to be renewed once-and the closing of pathways to permanent residency status for some senior executives. "The view of our profession generally is that a two-year visa will likely create unnecessary and often irreconcilable risk both for Australian companies whose investors seek leadership certainty while, at the same time,  top candidates seek both flexible, and long term contracts, of more than four years duration," said Mr Willis.

AESC noted that lack of employment security reduces the attractiveness of senior executive positions to overseas talent not available locally. AESC members also expressed concern that the closing of the pathway to permanent residency for company sponsored executives will create a talent vacuum-a loss of long term capability building Australia's talent ranks-and  executives who have, historically, made long-term contributions to Australia.

"Executive Search and Leadership Consulting firms fully appreciate the depth of executive talent within the country, and understand the intention and desire of this legislation to protect opportunities available to Australian citizens," said Steve Mullinjer, AESC Global Vice Chair and Chair of AESC's Council of Asia Pacific and the Middle East. "However, for true economic opportunities for Australia and its citizens, it is essential that Australian companies have access to talent that can best deliver the greatest business outcomes." He reinforced the point that AESC's experience confirmed that high performance from any company requires leadership expertise that is diverse, experienced and can drive transformation and change.

"AESC members play a critical role in ensuring that organisations have the greatest competitive advantage-a direct pipeline of outstanding talent to encourage and facilitate greater output, innovation and productivity," said Mr Mullinjer. "To best position Australian business to be competitive on an international scale and reward prosperity for Australia, AESC and its Australian membership, we urge the government to reconsider the unintended consequences of the legislation." 

About the Association of Executive Search and Leadership Consultants
AESC is the voice of excellence for the executive search and leadership consulting profession worldwide. Its rigorous Code of Professional Practice guides our members in nearly 1,300 offices in 74 countries and beyond to serve as strategic advisors on behalf of their clients. In turn, AESC members are best positioned to provide companies with a competitive advantage-the ability to find, attract and develop the best talent in the world and ensure that executives are successfully integrated.

By virtue of selecting an AESC member, clients can be secure in their choice of consulting firm, and can reap the benefits that only a trusted advisor can deliver. To learn more about AESC and to view a list of AESC members, visit www.aesc.org. To learn more about AESC's career service for executive-level candidates, visit www.bluesteps.com.

Contact:
Joe Chappell, AESC
jchappell@aesc.org 
+ 1 (212) 398 9556 ext. 236




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Association of Executive Search & Leadership Consultants (AESC) via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Corline Biomedical AB: Patientrekrytering startar i Renaparin-studie30.11.2018 16:37Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att patientrekrytering i den kliniska fas 1-studien RENAPAIR-01 startar. I studien utvärderas bolagets läkemedelskandidat Renaparin® som är under utveckling för att förbättra utfallet av njurtransplantation. Patienter kommer inledningsvis att rekryteras på Akademiska sjukhuset i Uppsala. När de fyra första patienterna utvärderats inleds också rekrytering på Karolinska Universitetssjukhuset i Huddinge. Beskedet att patientrekrytering startar innebär att förberedelsearbetet inför studiestart är avslutat och att till exempel avtal, initieringsmöte, logistik, provhantering och monitorering är hanterat, samt att godkänt prövningsläkemedel nu finns tillgängligt för rekvirering av kirurgerna på transplantationskliniken i Uppsala för dosering till donatornjurar. När första patient doserats kommer detta meddelas separat. Corline har utvecklat och äger rättigheterna till Renaparin® som administreras direkt till den donerade njuren i

Stillfront: Bytro Labs lanserar en ny version av Supremacy 191427.11.2018 08:00Pressmeddelande

PRESSMEDDELANDE 2018-11-27 Bytro Labs, en studio inom Stillfront Group, lanserar en ny version av Supremacy 1914 Spelutvecklaren Bytro Labs, mest kända för sitt framgångsrika strategispel Call of War, har släppt en ny version av sin klassiska speltitel Supremacy 1914. Dagens lansering är den första av tre milstolpar för den nya versionen av Supremacy 1914 - The Great War som släpps 2019. Den första uppdateringen innehåller en komplett omarbetning av området för spelets community, ett nytt utseende för kartan samt ny 3D-teknologi. I nästa steg kommer Bytro Labs att gå vidare till "true cross platform" där spelet tillgängliggörs för fler plattformar, en strategi som tidigare har varit framgångsrik för titeln Call of War. Supremacy 1914 - The Great War släpps för Android senare i år och i början av 2019 släpps spelet för iOS och Steam. Det tredje och sista steget i lanseringen kommer i mitten av 2019 innehållande en större uppdatering avseende både innehåll och funktion, som färdigställer

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum